Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q2 2024 Earnings

14MayConfirmed

Q4 2023

Q2 2024

-5.67

-4.06

-2.45

-0.84

Details

Expected EPS

-0.8374

Actual EPS

-1.19

Surprise EPS

-0.35

Surprise Percent

+42.11%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -1.19 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.